Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The landscape of cancer treatment is continually evolving, with a growing emphasis on precision medicine and targeted therapies. Among the promising advancements in this field is the development of synthetic peptides that can specifically target and destroy cancer cells while sparing healthy tissues. One such compound generating significant interest is PNC-27, a synthetic anti-cancer peptide that exemplifies this targeted approach.
PNC-27's primary mode of action is its ability to act as a membrane-active peptide. This means it interacts directly with the cell membrane, a crucial interface for cellular function and signaling. Specifically, PNC-27 is designed to bind to the HDM-2 protein, a protein frequently overexpressed on the surface of various cancer cells. This targeted interaction is the cornerstone of its therapeutic efficacy.
Upon binding to HDM-2, PNC-27 initiates a cascade effect that leads to the formation of pores within the cancer cell membrane. This disruption of the membrane integrity ultimately results in the cell's death through a process known as necrosis. The selectivity of PNC-27 is a key advantage, as it primarily affects cancer cells, minimizing collateral damage to normal, healthy cells. This targeted approach is essential for reducing the debilitating side effects often associated with conventional cancer treatments.
Furthermore, research indicates that PNC-27 can induce tumor cell necrosis independently of the p53 pathway. The p53 protein is a critical tumor suppressor, and its activation status can influence the effectiveness of some therapies. PNC-27's ability to bypass this dependency makes it a versatile candidate for a broader spectrum of cancer types, including those that may have mutations or dysregulation in the p53 pathway. Understanding this PNC-27 p53-independent action is vital for its clinical translation.
For those seeking to buy this innovative compound, it is important to source from a reputable manufacturer. As a leading supplier of pharmaceutical ingredients in China, we are dedicated to providing high-purity PNC-27. Our commitment to quality ensures that researchers and developers can rely on us for their critical projects. Exploring the PNC-27 HDM-2 protein interaction and its downstream effects is an active area of research, promising new avenues for therapeutic intervention. Consider us your trusted source for PNC-27 peptide, enabling advancements in targeted cancer therapy.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
